For help on how to get the results you want, see our search tips.
2 results
Medicine type
Accelerated assessment Remove Accelerated assessment filter
Additional monitoring Remove Additional monitoring filter
Exceptional circumstances Remove Exceptional circumstances filter
Medicine
Referrals Remove Referrals filter
Withdrawn applications Remove Withdrawn applications filter
Referral authorisation model
Centrally and nationally authorised products (mixed) Remove Centrally and nationally authorised products (mixed) filter
Centrally authorised product(s) Remove Centrally authorised product(s) filter
Referral PRAC recommendation
Suspension Remove Suspension filter
Risk minimisation measures Remove Risk minimisation measures filter
Referral safety status
Yes Remove Yes filter
Categories
Human Remove Human filter
Referral decision making model
PRAC-CHMP-EC Remove PRAC-CHMP-EC filter
-
List item
Referral: Picato
ingenol mebutate, associated names: Picato, Article 20 procedures
Status: European Commission final decision, opinion/position date: 30/04/2020, EC decision date: 06/07/2020, Last updated: 16/11/2020 -
List item
Referral: Lemtrada
alemtuzumab, associated names: Lemtrada, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 16/01/2020, Last updated: 04/02/2020